Lachlan Brown

Stock Analyst at William Blair

(2.32)
# 2,611
Out of 5,157 analysts
11
Total ratings
55.56%
Success rate
9.85%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $29.94
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $145.26
Upside: +37.68%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $36.25
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.81
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $10.05
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $433.92
Upside: +38.27%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $293.05
Upside: +19.43%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $19.62
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $69.66
Upside: +29.20%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $59.60
Upside: +269.13%